Genetically Engineered Artificial Exosome-Constructed Hydrogel for Ovarian Cancer Therapy-Reference-Cited by-同舟云学术

Genetically Engineered Artificial Exosome-Constructed Hydrogel for Ovarian Cancer Therapy

Published:2023-05-17 Issue:11 Volume:17 Page:10376-10392
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Li Qian¹^ORCID,Song Qingxu¹²,Zhao Zhipeng¹,Lin Yang¹,Cheng Yufeng²^ORCID,Karin Nathan³,Luan Yuxia¹^ORCID

Affiliation:

1. Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, China

2. Department of Radiation Oncology, Qilu Hospital of Shandong University, Jinan 250012, China

3. Department of Immunology, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 32000, Israel

Funder

Israel Science Foundation

Fundamental Research Funds for the Central Universities

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.3c00804

Reference30 articles.

1. High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints

2. Exploiting epigenetic dependencies in ovarian cancer therapy

3. FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication

4. Granulosa Cell Tumor of the Ovary

5. Two physically, functionally, and developmentally distinct peritoneal macrophage subsets

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A peptide-salinomycin conjugate with a bystander effect reduces the stemness characteristics of ovarian cancer cells and enhances drug sensitivity;European Journal of Medicinal Chemistry;2024-10

2. The study of designing a controlled drug release using oxaliplatin-loaded hydrogel for ovarian cancer treatment;Journal of the Taiwan Institute of Chemical Engineers;2024-10

3. Immune checkpoint-regulatable hydrogel-immobilized nanotherapeutics for post-surgical treatment of osteosarcoma;Chemical Engineering Journal;2024-10

4. Exosomes: Key Factors in Ovarian Cancer Peritoneal Metastasis and Drug Resistance;Biomolecules;2024-09-02

5. Methotrexate-modified docetaxel liposome targeting with ginsenoside Rh2 as a membrane stabilizer for the treatment of ovarian cancer;Journal of Drug Delivery Science and Technology;2024-09